Home
About
Leadership
Technology
Pipeline
News
Careers
Contact

Recent Posts

Artiva Biotherapeutics Appoints Michael E. Faerm as Chief Financial Officer
Artiva Biotherapeutics Raises $120 Million in Series B Financing to Advance Pipeline of Allogeneic NK Cell Therapies
Artiva Biotherapeutics Announces Exclusive Worldwide Collaboration and License Agreement with Merck to Develop Candidate CAR-NK Cell Therapies
Artiva Biotherapeutics Announces Appointment of Dr. Fred Aslan as President and CEO
Artiva Biotherapeutics Announces FDA Allowance of IND to Initiate Clinical Trials of AB-101 in Combination with Rituximab for the Treatment of Advanced B-cell Lymphomas

Archives

April 2021
February 2021
January 2021
December 2020
November 2020
June 2020

Categories

Press Releases

Archives

April 2021
February 2021
January 2021
December 2020
November 2020
June 2020

Category: Executives

Fred Aslan, M.D.

Jennifer Bush

Michael Faerm

Tom Farrell

Peter Flynn, Ph.D.

Jason Litten, M.D.

Esther van den Boom, CPA

Eugene Helsel

John Lim, Pharm.D.

Heather Raymon, Ph.D.

Privacy Policy
Terms

© Artiva Biotherapeutics, Inc., 2021

Sign up for news updates

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.AcceptPrivacy Policy